CN Stock MarketDetailed Quotes

301075 Tibet Duo Rui Pharmaceutical

Watchlist
  • 18.87
  • +0.17+0.91%
Market Closed Dec 27 15:00 CST
1.51BMarket Cap-86.16P/E (TTM)

Tibet Duo Rui Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-40.12%255.4M
-43.00%271.69M
-34.82%326.22M
-4.81%405.27M
-20.22%426.52M
-18.72%476.64M
-11.22%500.49M
-30.31%425.76M
-16.12%534.62M
312.00%586.4M
Transactional financial assets
76.91%141.53M
135.42%141.25M
211.78%187.07M
-3.04%77.57M
--80M
--60M
--60M
--80M
----
----
Notes receivable and accounts receivable
35.10%95.61M
50.92%104.96M
11.93%83.18M
-9.67%82.24M
-19.56%70.77M
-17.47%69.55M
6.53%74.32M
-7.38%91.04M
-9.35%87.98M
0.55%84.27M
-Notes receivable
--51.99K
--328.42K
-84.44%330.27K
55.49%2.5M
----
----
--2.12M
--1.61M
--190K
--190K
-Accounts receivable
35.02%95.56M
50.45%104.63M
14.76%82.85M
-10.84%79.74M
-19.38%70.77M
-17.28%69.55M
3.49%72.19M
-9.01%89.43M
-9.54%87.79M
0.33%84.08M
Other receivables (including interest and dividends)
-18.90%9.7M
6.85%9.9M
77.54%13.65M
42.13%11.2M
-64.10%11.96M
-0.90%9.26M
-8.37%7.69M
245.79%7.88M
1,137.93%33.31M
48.63%9.35M
-Other receivable
----
6.85%9.9M
----
----
----
-0.90%9.26M
----
245.79%7.88M
----
--9.35M
Advance payment
-24.66%36.75M
-9.97%28.01M
203.59%30.67M
289.49%26.69M
105.93%48.78M
128.13%31.11M
-70.29%10.1M
38.62%6.85M
206.97%23.69M
320.97%13.64M
Inventories
97.55%60.12M
127.01%43.82M
49.34%31.37M
1.10%33.13M
120.17%30.43M
6.31%19.3M
74.46%21.01M
233.55%32.77M
89.50%13.82M
35.15%18.16M
Receivable financing
--1.27M
--39.14K
-96.39%39.14K
158.83%3.27M
----
----
-70.76%1.08M
-37.91%1.26M
52.45%5.28M
107.24%5.88M
Other current assets
78.11%14.86M
971.31%11.67M
678.78%10.17M
415.10%9.59M
1,010.43%8.35M
-2.01%1.09M
80.05%1.31M
147.94%1.86M
14.97%751.57K
-75.82%1.11M
Total current assets
-9.09%615.26M
-8.34%611.34M
0.94%682.37M
0.24%648.95M
-3.24%676.81M
-7.21%666.95M
-2.37%676M
-11.20%647.43M
-7.51%699.46M
180.20%718.8M
Non Current assets
Other equity investment
88.26%70.8M
40.03%67.8M
109.53%78.8M
134.33%69.61M
-26.26%37.61M
202.60%48.42M
526.76%37.61M
--29.7M
--51M
--16M
Long-term equity investment
-18.15%100.06M
18.84%98.42M
4.80%87.06M
3.42%85.75M
--122.24M
--82.81M
730.66%83.07M
--82.92M
----
----
Fixed assets
----
93.31%192.56M
----
----
----
-9.34%99.61M
----
3.00%105.27M
----
--109.88M
Constru in process
----
373.52%19.05M
----
----
----
1,672.07%4.02M
----
1,006.57%3.94M
----
--226.99K
Intangible assets
-3.49%33.38M
58.05%33.66M
59.33%33.93M
60.98%34.19M
61.52%34.58M
0.28%21.29M
27.21%21.3M
26.02%21.24M
26.19%21.41M
24.31%21.23M
Goodwill
27.94%3.89M
--3.89M
--3.88M
--3.69M
--3.04M
----
----
----
----
----
Long deferred expense
191.48%2.72M
250.32%2.78M
918.03%3.35M
725.44%2.7M
-22.77%931.71K
-11.38%792.76K
-71.98%329.29K
-77.53%327.12K
-30.51%1.21M
-55.64%894.52K
Deferred tax assets
-16.61%1.19M
49.54%1.21M
125.48%1.3M
61.05%1.25M
120.95%1.42M
34.01%807.96K
-40.86%576.33K
19.17%778.51K
-1.24%644.07K
21.84%602.89K
Usufruct assets
213.14%2.76M
134.85%2.76M
-44.44%733.2K
-40.00%879.85K
--879.85K
317.35%1.17M
134.76%1.32M
73.89%1.47M
----
--281.09K
Other non current assets
510.11%30.51M
-39.39%17.08M
223.53%16.18M
181.54%16.33M
11.21%5M
526.70%28.18M
-66.67%5M
--5.8M
--4.5M
--4.5M
Total non current assets
12.12%454.75M
52.97%439.19M
69.45%434.05M
68.36%423.32M
115.79%405.59M
86.90%287.11M
71.20%256.16M
105.48%251.44M
49.71%187.96M
21.05%153.61M
Total assets
-1.15%1.07B
10.11%1.05B
19.77%1.12B
19.29%1.07B
21.97%1.08B
9.36%954.06M
10.70%932.16M
5.57%898.87M
0.64%887.41M
127.53%872.41M
Liabilities
Current liabilities
Short term loan
-85.80%25.02M
-84.62%25.02M
-50.18%74.94M
-49.90%50.13M
193.66%176.19M
171.22%162.73M
648.73%150.42M
400.26%100.06M
99.79%60M
99.79%60M
Notes payable and accounts payable
111.80%42.3M
505.87%23.67M
113.55%18.06M
120.72%26.77M
-58.92%19.97M
-90.28%3.91M
23.38%8.46M
-47.30%12.13M
25.77%48.62M
-31.17%40.19M
-Notes payable
----
----
----
--2.4M
-94.27%2.4M
----
----
----
--41.9M
--23.9M
-Accounts payable
140.73%42.3M
505.87%23.67M
113.55%18.06M
100.93%24.37M
161.38%17.57M
-76.02%3.91M
23.38%8.46M
-47.30%12.13M
-82.61%6.72M
-72.10%16.29M
Contract liabilities
-83.05%2.4M
-17.32%2.06M
23.46%3.25M
22.19%5.08M
612.70%14.15M
4.80%2.49M
-37.57%2.63M
11.88%4.16M
-24.15%1.99M
-32.96%2.38M
Salaries payable
22.14%3.92M
52.43%3.6M
5.33%3.03M
-5.45%5.69M
-26.26%3.21M
-46.05%2.36M
-1.62%2.88M
-18.63%6.02M
6.15%4.36M
52.05%4.37M
Taxs payable
-82.77%672K
-30.90%3.52M
-43.69%2.87M
-36.70%5.33M
-63.56%3.9M
-47.65%5.09M
-43.77%5.09M
39.66%8.42M
37.41%10.7M
-0.15%9.73M
Other payable (including interest and dividends)
-64.18%12.39M
658.19%11.77M
387.99%11.53M
73.87%21.88M
823.13%34.6M
-30.95%1.55M
113.19%2.36M
651.84%12.58M
-86.26%3.75M
21.31%2.25M
-Other payable
----
658.19%11.77M
----
----
----
-30.95%1.55M
----
651.84%12.58M
----
--2.25M
Non current liabilities due within one year
16,229.75%46.6M
1,149.21%3.6M
2,561.44%11.6M
3,892.17%11.6M
-43.53%285.39K
-41.88%288.02K
-8.39%435.98K
-38.93%290.65K
--505.43K
--495.59K
Other current liabilities
-83.05%311.82K
-17.14%267.77K
23.46%422.33K
196.50%2.7M
612.70%1.84M
4.58%323.17K
-37.57%342.07K
88.58%911.49K
-24.15%258.17K
-32.96%309.02K
Total current liabilities
-47.42%133.63M
-58.88%73.5M
-27.18%125.71M
-10.65%129.18M
95.24%254.16M
49.30%178.74M
281.32%172.62M
130.25%144.57M
17.46%130.17M
11.99%119.72M
Current liabilities
Long term loan
--165.07M
--188.12M
--188.22M
--118.08M
----
----
----
----
----
----
Deferred tax liabilities
1,918.90%888.16K
1,421.78%892.62K
--897.08K
--901.53K
--43.99K
--58.66K
----
----
----
----
Long term deferred income
-2.02%2.09M
--2.1M
--2.11M
--2.12M
--2.13M
----
----
----
----
----
Lease liabilities
557.68%2.18M
259.61%2.18M
-57.86%313.76K
-65.31%306K
--331.93K
--607.06K
--744.62K
--882.19K
----
----
Total non current liabilities
6,687.39%170.23M
28,935.65%193.29M
25,622.89%191.54M
13,662.26%121.41M
--2.51M
--665.71K
--744.62K
--882.19K
----
----
Total liabilities
18.39%303.86M
48.71%266.8M
83.00%317.25M
72.28%250.59M
97.17%256.67M
49.85%179.41M
282.96%173.36M
131.65%145.45M
16.50%130.17M
11.99%119.72M
Shareholders equity
Paid-in capital
0.00%80M
0.00%80M
0.00%80M
0.00%80M
0.00%80M
0.00%80M
0.00%80M
0.00%80M
0.00%80M
33.33%80M
Capital reserve funds
-0.09%509.05M
-0.08%509.08M
-0.08%509.12M
-0.06%509.22M
0.06%509.5M
-0.81%509.5M
-0.81%509.5M
-2.11%509.5M
-2.18%509.18M
778.72%513.65M
Surplus reserve funds
25.91%20.26M
25.91%20.26M
25.91%20.26M
25.91%20.26M
24.89%16.09M
24.89%16.09M
24.89%16.09M
24.89%16.09M
71.01%12.88M
71.01%12.88M
Retained profit
-18.92%134.97M
-7.89%148.77M
10.06%159.37M
9.97%161.91M
9.21%166.47M
12.35%161.52M
-23.15%144.81M
-17.99%147.23M
-8.02%152.42M
-6.31%143.77M
Less:Treasury stock
--20.99M
--20.99M
--20M
----
----
----
----
----
----
----
Other composite income
-89.76%676.1K
-89.76%676.1K
-87.96%795.41K
152.17%676.1K
--6.61M
--6.61M
--6.61M
---1.3M
----
----
Shareholders equity without minority interests
-7.02%723.97M
-4.64%737.8M
-0.99%749.55M
2.73%772.06M
3.21%778.66M
3.12%773.72M
-4.78%757.01M
-5.22%751.53M
-2.49%754.48M
168.51%750.3M
Minority interests
-10.39%42.18M
4,839.51%45.93M
2,680.36%49.64M
2,526.72%49.61M
1,606.72%47.07M
-61.10%929.88K
0.03%1.79M
144.08%1.89M
174.64%2.76M
182.25%2.39M
Total shareholder equity
-7.22%766.15M
1.17%783.73M
5.32%799.18M
9.06%821.68M
9.05%825.73M
2.92%774.65M
-4.76%758.8M
-4.47%753.41M
-1.66%757.24M
172.19%752.69M
Total liabilityies and equity
-1.15%1.07B
10.11%1.05B
19.77%1.12B
19.29%1.07B
21.97%1.08B
9.36%954.06M
10.70%932.16M
5.57%898.87M
0.64%887.41M
127.53%872.41M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -40.12%255.4M-43.00%271.69M-34.82%326.22M-4.81%405.27M-20.22%426.52M-18.72%476.64M-11.22%500.49M-30.31%425.76M-16.12%534.62M312.00%586.4M
Transactional financial assets 76.91%141.53M135.42%141.25M211.78%187.07M-3.04%77.57M--80M--60M--60M--80M--------
Notes receivable and accounts receivable 35.10%95.61M50.92%104.96M11.93%83.18M-9.67%82.24M-19.56%70.77M-17.47%69.55M6.53%74.32M-7.38%91.04M-9.35%87.98M0.55%84.27M
-Notes receivable --51.99K--328.42K-84.44%330.27K55.49%2.5M----------2.12M--1.61M--190K--190K
-Accounts receivable 35.02%95.56M50.45%104.63M14.76%82.85M-10.84%79.74M-19.38%70.77M-17.28%69.55M3.49%72.19M-9.01%89.43M-9.54%87.79M0.33%84.08M
Other receivables (including interest and dividends) -18.90%9.7M6.85%9.9M77.54%13.65M42.13%11.2M-64.10%11.96M-0.90%9.26M-8.37%7.69M245.79%7.88M1,137.93%33.31M48.63%9.35M
-Other receivable ----6.85%9.9M-------------0.90%9.26M----245.79%7.88M------9.35M
Advance payment -24.66%36.75M-9.97%28.01M203.59%30.67M289.49%26.69M105.93%48.78M128.13%31.11M-70.29%10.1M38.62%6.85M206.97%23.69M320.97%13.64M
Inventories 97.55%60.12M127.01%43.82M49.34%31.37M1.10%33.13M120.17%30.43M6.31%19.3M74.46%21.01M233.55%32.77M89.50%13.82M35.15%18.16M
Receivable financing --1.27M--39.14K-96.39%39.14K158.83%3.27M---------70.76%1.08M-37.91%1.26M52.45%5.28M107.24%5.88M
Other current assets 78.11%14.86M971.31%11.67M678.78%10.17M415.10%9.59M1,010.43%8.35M-2.01%1.09M80.05%1.31M147.94%1.86M14.97%751.57K-75.82%1.11M
Total current assets -9.09%615.26M-8.34%611.34M0.94%682.37M0.24%648.95M-3.24%676.81M-7.21%666.95M-2.37%676M-11.20%647.43M-7.51%699.46M180.20%718.8M
Non Current assets
Other equity investment 88.26%70.8M40.03%67.8M109.53%78.8M134.33%69.61M-26.26%37.61M202.60%48.42M526.76%37.61M--29.7M--51M--16M
Long-term equity investment -18.15%100.06M18.84%98.42M4.80%87.06M3.42%85.75M--122.24M--82.81M730.66%83.07M--82.92M--------
Fixed assets ----93.31%192.56M-------------9.34%99.61M----3.00%105.27M------109.88M
Constru in process ----373.52%19.05M------------1,672.07%4.02M----1,006.57%3.94M------226.99K
Intangible assets -3.49%33.38M58.05%33.66M59.33%33.93M60.98%34.19M61.52%34.58M0.28%21.29M27.21%21.3M26.02%21.24M26.19%21.41M24.31%21.23M
Goodwill 27.94%3.89M--3.89M--3.88M--3.69M--3.04M--------------------
Long deferred expense 191.48%2.72M250.32%2.78M918.03%3.35M725.44%2.7M-22.77%931.71K-11.38%792.76K-71.98%329.29K-77.53%327.12K-30.51%1.21M-55.64%894.52K
Deferred tax assets -16.61%1.19M49.54%1.21M125.48%1.3M61.05%1.25M120.95%1.42M34.01%807.96K-40.86%576.33K19.17%778.51K-1.24%644.07K21.84%602.89K
Usufruct assets 213.14%2.76M134.85%2.76M-44.44%733.2K-40.00%879.85K--879.85K317.35%1.17M134.76%1.32M73.89%1.47M------281.09K
Other non current assets 510.11%30.51M-39.39%17.08M223.53%16.18M181.54%16.33M11.21%5M526.70%28.18M-66.67%5M--5.8M--4.5M--4.5M
Total non current assets 12.12%454.75M52.97%439.19M69.45%434.05M68.36%423.32M115.79%405.59M86.90%287.11M71.20%256.16M105.48%251.44M49.71%187.96M21.05%153.61M
Total assets -1.15%1.07B10.11%1.05B19.77%1.12B19.29%1.07B21.97%1.08B9.36%954.06M10.70%932.16M5.57%898.87M0.64%887.41M127.53%872.41M
Liabilities
Current liabilities
Short term loan -85.80%25.02M-84.62%25.02M-50.18%74.94M-49.90%50.13M193.66%176.19M171.22%162.73M648.73%150.42M400.26%100.06M99.79%60M99.79%60M
Notes payable and accounts payable 111.80%42.3M505.87%23.67M113.55%18.06M120.72%26.77M-58.92%19.97M-90.28%3.91M23.38%8.46M-47.30%12.13M25.77%48.62M-31.17%40.19M
-Notes payable --------------2.4M-94.27%2.4M--------------41.9M--23.9M
-Accounts payable 140.73%42.3M505.87%23.67M113.55%18.06M100.93%24.37M161.38%17.57M-76.02%3.91M23.38%8.46M-47.30%12.13M-82.61%6.72M-72.10%16.29M
Contract liabilities -83.05%2.4M-17.32%2.06M23.46%3.25M22.19%5.08M612.70%14.15M4.80%2.49M-37.57%2.63M11.88%4.16M-24.15%1.99M-32.96%2.38M
Salaries payable 22.14%3.92M52.43%3.6M5.33%3.03M-5.45%5.69M-26.26%3.21M-46.05%2.36M-1.62%2.88M-18.63%6.02M6.15%4.36M52.05%4.37M
Taxs payable -82.77%672K-30.90%3.52M-43.69%2.87M-36.70%5.33M-63.56%3.9M-47.65%5.09M-43.77%5.09M39.66%8.42M37.41%10.7M-0.15%9.73M
Other payable (including interest and dividends) -64.18%12.39M658.19%11.77M387.99%11.53M73.87%21.88M823.13%34.6M-30.95%1.55M113.19%2.36M651.84%12.58M-86.26%3.75M21.31%2.25M
-Other payable ----658.19%11.77M-------------30.95%1.55M----651.84%12.58M------2.25M
Non current liabilities due within one year 16,229.75%46.6M1,149.21%3.6M2,561.44%11.6M3,892.17%11.6M-43.53%285.39K-41.88%288.02K-8.39%435.98K-38.93%290.65K--505.43K--495.59K
Other current liabilities -83.05%311.82K-17.14%267.77K23.46%422.33K196.50%2.7M612.70%1.84M4.58%323.17K-37.57%342.07K88.58%911.49K-24.15%258.17K-32.96%309.02K
Total current liabilities -47.42%133.63M-58.88%73.5M-27.18%125.71M-10.65%129.18M95.24%254.16M49.30%178.74M281.32%172.62M130.25%144.57M17.46%130.17M11.99%119.72M
Current liabilities
Long term loan --165.07M--188.12M--188.22M--118.08M------------------------
Deferred tax liabilities 1,918.90%888.16K1,421.78%892.62K--897.08K--901.53K--43.99K--58.66K----------------
Long term deferred income -2.02%2.09M--2.1M--2.11M--2.12M--2.13M--------------------
Lease liabilities 557.68%2.18M259.61%2.18M-57.86%313.76K-65.31%306K--331.93K--607.06K--744.62K--882.19K--------
Total non current liabilities 6,687.39%170.23M28,935.65%193.29M25,622.89%191.54M13,662.26%121.41M--2.51M--665.71K--744.62K--882.19K--------
Total liabilities 18.39%303.86M48.71%266.8M83.00%317.25M72.28%250.59M97.17%256.67M49.85%179.41M282.96%173.36M131.65%145.45M16.50%130.17M11.99%119.72M
Shareholders equity
Paid-in capital 0.00%80M0.00%80M0.00%80M0.00%80M0.00%80M0.00%80M0.00%80M0.00%80M0.00%80M33.33%80M
Capital reserve funds -0.09%509.05M-0.08%509.08M-0.08%509.12M-0.06%509.22M0.06%509.5M-0.81%509.5M-0.81%509.5M-2.11%509.5M-2.18%509.18M778.72%513.65M
Surplus reserve funds 25.91%20.26M25.91%20.26M25.91%20.26M25.91%20.26M24.89%16.09M24.89%16.09M24.89%16.09M24.89%16.09M71.01%12.88M71.01%12.88M
Retained profit -18.92%134.97M-7.89%148.77M10.06%159.37M9.97%161.91M9.21%166.47M12.35%161.52M-23.15%144.81M-17.99%147.23M-8.02%152.42M-6.31%143.77M
Less:Treasury stock --20.99M--20.99M--20M----------------------------
Other composite income -89.76%676.1K-89.76%676.1K-87.96%795.41K152.17%676.1K--6.61M--6.61M--6.61M---1.3M--------
Shareholders equity without minority interests -7.02%723.97M-4.64%737.8M-0.99%749.55M2.73%772.06M3.21%778.66M3.12%773.72M-4.78%757.01M-5.22%751.53M-2.49%754.48M168.51%750.3M
Minority interests -10.39%42.18M4,839.51%45.93M2,680.36%49.64M2,526.72%49.61M1,606.72%47.07M-61.10%929.88K0.03%1.79M144.08%1.89M174.64%2.76M182.25%2.39M
Total shareholder equity -7.22%766.15M1.17%783.73M5.32%799.18M9.06%821.68M9.05%825.73M2.92%774.65M-4.76%758.8M-4.47%753.41M-1.66%757.24M172.19%752.69M
Total liabilityies and equity -1.15%1.07B10.11%1.05B19.77%1.12B19.29%1.07B21.97%1.08B9.36%954.06M10.70%932.16M5.57%898.87M0.64%887.41M127.53%872.41M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Biomedical
Biomedical
Intraday+0.69%
Western Development
Western Development
Intraday+0.60%